JPRN-UMIN000013050已完成未知
Angiotensin receptor blocker/Calcium antagonist combination therapy on diurnal blood pressure variation - Angiotensin receptor blocker/Calcium antagonist combination therapy on diurnal blood pressure variation
Jichi Medical University School of Medicine0 个研究点目标入组 200 人开始时间: 2014年2月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet one of the following criteria are excluded: 1)Secondary hypertension 2)Congestive heart failure; onset of acute myocardial infarction in the past 6 month; onset of cerebrovascular disturbance in the past 6 month; current atrial fibrillation or atrioventricular block or severe arrhythmia. 3)hepatic insufficiency (AST or ALT >X2 the upper limit of the normal range) , renal insufficiency (serum Crl.>1.5mg/dL) 4)Diabetic patients being treated with aliskiren. 5)Allergy or drug hypersensitivity. 6)Lack of the informed consent for any reason (e.g. dementia). 7)Women suspected of being pregnant. 8)Patients being ineligible by the attending physicians.
研究者
相似试验
进行中(未招募)
不适用
ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuriaThe primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first achieved with unique pharmacological class then shifting to the association of the two classes as soon as ineffective blockade is documentedMedDRA version: 9.1Level: SOCClassification code 10038359Term: Renal and urinary disordersEUCTR2005-003885-40-ITAZIENDA OSPEDALIERA PROVINCIALE DI LECCO
已完成
不适用
Angiotensin Converting Enzyme (ACE) inhibition for the preservation of renal function and patient survival in kidney transplantatioChronic kidney disease in renal transplant patientsUrological and Genital DiseasesChronic kidney diseaseISRCTN78129473Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute528
招募中
不适用
Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failureAcute myocardial infarctionJPRN-UMIN000046004Chiba University Hospital1,000
已完成
不适用
The role of angiotensine receptor blocker treatment in patients with rheumatoid arthritis: evaluate of endothelial functioRheumatoid arthritisJPRN-UMIN000008536Kawasaki Medical School50
招募中
不适用
Management of angiotensin inhibitors during the perioperative period.on-cardiac major surgeryNL-OMON25483niversity Medical Center Utrecht, The Netherlands3,200
